An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Title | PMID | PMCID | Public Release Type | Publication Year | DOI | Study Acronym | Study Network | Request ID(s) | Public Release Origin |
|---|---|---|---|---|---|---|---|---|---|
| Association Between Polypharmacy, Patient Reported Symptoms, and Quality of Life among Nonalcoholic Fatty Liver Disease Patients in the United States. | Journal | 2022 | 10.1007/s40267-022-00957-z | NAFLD Adult, PIVENS, NAFLD Pediatric, TONIC | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23211 | Secondary Research | ||
| Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life | 35903833 | PMC9512481 | Journal | 2022 | 10.1002/hep4.2044 | PIVENS, FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23138 | Secondary Research |
| Changes in Serum Cytokeratin 18 Levels Significantly Predict Changes in Liver Histology in Adults With Nonalcoholic Steatohepatitis: Results From the Pivens Trial | Journal | 2013 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | ||||
| Effect of Polypharmacy on Health-related Quality of Life in Pediatric Patients with Nonalcoholic Fatty Liver Disease in the United States. | Journal | 2024 | NAFLD Adult, TONIC, PIVENS, NAFLD Pediatric | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23211 | Secondary Research | |||
| Elevated Serum Ferritin Values Above the Upper Limit of Normal Are Associated With Laboratory and Histologic Evidence of Increased NASH Severity, but Not the Presence of Diabetes or Metabolic Syndrome Among Patients in the NASH CRN | Journal | 2011 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | ||||
| Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials. | 24759732 | PMC3997354 | Journal | 2014 | 10.1371/journal.pone.0095366 | PIVENS, TONIC | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | |
| HSD17B13 is a Hepatic Retinol Dehydrogenase Associated with Histological Features of Non-Alcoholic Fatty Liver Disease | 30415504 | PMC6438737 | Journal | 2018 | 10.1002/hep.30350 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 20860 | Secondary Research |
| Histologic Predictors of Improvement in Fibrosis in NASH: Results from the Clinical Research Network PIVENS Trial | Journal | 2012 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | ||||
| Metabolomic Profiling to Define Predictors of Response to Vitamin E for Non- Alcoholic Steatohepatitis (NASH) | Journal | 2011 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | ||||
| Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. | 18804555 | PMC2929909 | Journal | 2009 | 10.1016/j.cct.2008.09.003 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | |
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. | 20427778 | PMC2928471 | Journal | 2010 | 10.1056/NEJMoa0907929 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | |
| Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH): What Is the Mechanism? | Journal | 2013 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | ||||
| The Effect of Polypharmacy on Quality of Life in Adult Patients with Nonalcoholic Fatty Liver Disease in the United States. | 35064417 | Journal | 2022 | 10.1007/s11136-022-03090-6 | TONIC, NAFLD Pediatric, PIVENS, NAFLD Adult | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23211 | Secondary Research | |
| The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis | 37933187 | Journal | 2024 | 10.1080/03007995.2023.2279676 | FLINT, CyNCh, NAFLD Adult, NAFLD Pediatric, PIVENS, TONIC | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23059 | Secondary Research | |
| Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. | 24849310 | PMC4241186 | Journal | 2015 | 10.1002/hep.27235 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | |
| Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-alcoholic Steatohepatitis | 32506513 | PMC7719569 | Journal | 2020 | 10.1111/jgh.15131 | PIVENS | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 22055 | Secondary Research |
- Previous
- 1(current)
- Next